Metagenics, Inc.   Report issue

For profit Phase 1
Founded: Aliso Viejo CA United States (1983)
Status: No NME R&D (1983)

Organization Overview

First Clinical Trial
2011
NCT01656681
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Metagenics Europe | Metagenics, Inc. | MetaProteomics LLC | MetaProteomics / Metagenics | MetaProteomics / Metagenics / FMRC